title: Outcomes of reenclavation of subluxated iris-fixated phakic intraocular lenses: comparison with primary surgery outcomes.
abstract: OBJECTIVE
  To study the outcomes of successful reenclavation of subluxated iris-fixated phakic intraocular lenses (pIOLs).
  
  
  METHODS
  Tertiary eyecare referral center.
  
  
  METHODS
  Interventional case series comprised eyes with a subluxated Verisyse pIOL that had successful reenclavation of 1 haptic. A comparison of outcomes between primary pIOL implantation surgery and subsequent reenclavation was performed. The parameters were uncorrected (UDVA) and corrected (CDVA) distance visual acuity and the quantitative endothelial changes preoperatively and postoperatively at 1 week and 1, 3, and 6 months.
  
  
  RESULTS
  Nine eyes of 6 patients were evaluated. Disenclavation was spontaneous in 6 eyes (66.6%) and posttraumatic in 3 eyes (33.3%). The mean UDVA and CDVA at 6 months were comparable between primary surgery and reenclavation. The subluxation and subsequent reenclavation did not cause statistically significant endothelial cell loss; endothelial cell loss after reenclavation was comparable to that after primary surgery (P = .953).
  
  
  CONCLUSIONS
  Successful subluxation of iris-fixated pIOLs did not cause significant damage to the ocular structures or lead to serious complications.
authors.affiliation: Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: Jeewan S
authors.initials: JS
authors.lastname: Titiyal
authors.forename: Namrata
authors.initials: N
authors.lastname: Sharma
authors.forename: Rashim
authors.initials: R
authors.lastname: Mannan
authors.forename: Archna
authors.initials: A
authors.lastname: Pruthi
authors.forename: Rasik B
authors.initials: RB
authors.lastname: Vajpayee
mesh_terms: D000293:Adolescent; D000328:Adult; D002452:Cell Count; D055954:Corneal Endothelial Cell Loss / Q000209:etiology; D004728:Endothelium, Corneal / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D019654:Lens Implantation, Intraocular / Q000379:methods*; D008297:Male; D008916:Miotics / Q000008:administration & dosage; D009216:Myopia / Q000503:physiopathology / Q000601:surgery*; D054120:Phakic Intraocular Lenses; D010862:Pilocarpine / Q000008:administration & dosage; D011475:Prosthesis Failure; D011680:Pupil / Q000187:drug effects; D012086:Reoperation; D012189:Retrospective Studies; D016896:Treatment Outcome; D014792:Visual Acuity / Q000502:physiology; D055815:Young Adult
chemical_list: D008916:Miotics; D010862:Pilocarpine